| Alprolix |
125444 |
005 |
351(a) |
Coagulation Factor IX (Recombinant), Fc Fusion Protein |
For Injection |
Intravenous |
250IU |
Single-Dose Vial |
2016/02/18
|
Bioverativ Therapeutics, Inc. |
Rx |
Licensed |
|
N/A |
|
125585 |
001 |
351(a) |
HPC, Cord Blood |
Injection |
Intravenous |
5X10^8 NUCLEATED CELLS CONTENT WITH 85% VIABILITY & 1.25X10^6 VIABLE CD34+ CELLS (PRE-CRYOPRESERVATION) |
Bag |
2016/01/28
|
Bloodworks |
Rx |
Licensed |
|
N/A |
| Humulin R U-500 |
018780 |
002 |
351(a) |
insulin human |
Injection |
Subcutaneous |
1,500UNITS/3ML (500UNITS/ML) |
Autoinjector |
2015/12/29
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Ixinity |
125426 |
004 |
351(a) |
Coagulation Factor IX (Recombinant) |
For Injection |
Intravenous |
250IU |
Single-Dose Vial |
2015/12/21
|
Medexus Pharma, Inc. |
Disc |
Licensed |
|
N/A |
| Ixinity |
125426 |
005 |
351(a) |
Coagulation Factor IX (Recombinant) |
For Injection |
Intravenous |
3000IU |
Single-Dose Vial |
2015/12/21
|
Medexus Pharma, Inc. |
Rx |
Licensed |
|
N/A |
| Ixinity |
125426 |
006 |
351(a) |
Coagulation Factor IX (Recombinant) |
For Injection |
Intravenous |
2000IU |
Single-Dose Vial |
2015/12/21
|
Medexus Pharma, Inc. |
Disc |
Licensed |
|
N/A |
| Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized |
103649 |
017 |
351(a) |
Rho(D) Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
15000IU |
Vial |
2015/12/18
|
Kamada Ltd. |
Disc |
Licensed |
|
N/A |
| Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized |
103649 |
018 |
351(a) |
Rho(D) Immune Globulin Intravenous (Human) |
Injection |
Intramuscular |
15000IU |
Vial |
2015/12/18
|
Kamada Ltd. |
Disc |
Licensed |
|
N/A |
| Basaglar |
205692 |
001 |
351(a) |
insulin glargine |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
2015/12/16
|
Eli Lilly and Company |
Disc |
Licensed |
N/A |
N/A |
| Kanuma |
125561 |
001 |
351(a) |
sebelipase alfa |
Injection |
Intravenous |
20MG/10ML (2MG/ML) |
Single-Dose Vial |
2015/12/08
|
Alexion Pharmaceuticals, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Vonvendi |
125577 |
001 |
351(a) |
von Willebrand factor (Recombinant) |
For Injection |
Intravenous |
1300IU |
Single-Dose Vial |
2015/12/08
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Vonvendi |
125577 |
002 |
351(a) |
von Willebrand factor (Recombinant) |
For Injection |
Intravenous |
650IU |
Single-Dose Vial |
2015/12/08
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Empliciti |
761035 |
001 |
351(a) |
elotuzumab |
For Injection |
Intravenous |
300MG |
Single-Dose Vial |
2015/11/30
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
| Empliciti |
761035 |
002 |
351(a) |
elotuzumab |
For Injection |
Intravenous |
400MG |
Single-Dose Vial |
2015/11/30
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
| Fluad |
125510 |
001 |
351(a) |
Influenza Vaccine, Adjuvanted |
Injection |
Intramuscular |
45UG/.5ML |
Pre-Filled Syringe |
2015/11/24
|
Seqirus Inc. |
Disc |
Licensed |
|
N/A |
| Portrazza |
125547 |
001 |
351(a) |
necitumumab |
Injection |
Intravenous |
800MG/50ML (16MG/ML) |
Single-Dose Vial |
2015/11/24
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Humira |
125057 |
006 |
351(a) |
adalimumab |
Injection |
Subcutaneous |
40MG/0.4ML |
Pre-Filled Syringe |
2015/11/23
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Xeomin |
125360 |
003 |
351(a) |
incobotulinumtoxinA |
For Injection |
Intramuscular, Intraglandular |
200UNITS |
Single-Dose Vial |
2015/11/20
|
Merz Pharmaceuticals GmbH c/o Merz Pharmaceuticals LLC |
Rx |
Licensed |
N/A |
N/A |
| Darzalex |
761036 |
001 |
351(a) |
daratumumab |
Injection |
Intravenous |
100MG/5ML |
Single-Dose Vial |
2015/11/16
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Darzalex |
761036 |
002 |
351(a) |
daratumumab |
Injection |
Intravenous |
400MG/20ML |
Single-Dose Vial |
2015/11/16
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |